Assessment of the impact of targeted therapy on metastatic bone disease in renal cancer

Eur Urol. 2014 Sep;66(3):510-1. doi: 10.1016/j.eururo.2014.03.042. Epub 2014 Apr 13.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Carcinoma, Renal Cell / drug therapy*
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Imidazoles / therapeutic use*
  • Kidney Neoplasms / drug therapy*
  • Male

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles